GlycoMimetics, Inc. (NASDAQ:GLYC) is now up 28.83% compared to a 12-month low of $8.29. We have seen the price to move -2.73% lower and get settled at $10.68 on 01/11/2019. At recent session, it appeared stuck in a range of $10.5 to $10.95. This company shares are 137.83% off its target price of $25.4 and the current market capitalization stands at $473.55M. The recent change has given its price a -4.94% deficit over SMA 50 and -59% deficit over its 52-week high. The stock witnessed 0.66% gains, -18.22% declines and -36.5% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found GLYC’s volatility during a week at 4.97% and during a month it has been found around 7.64%.GlycoMimetics, Inc. (GLYC) Top Holders
Institutional investors currently hold around $497 million or 0% in GLYC stock. Look at its top three institutional owners. Nea Management Company, Llc owns $97.07 million in GlycoMimetics, Inc., which represents roughly 20.5% of the company’s market cap and approximately 19.53% of the institutional ownership. Similar statistics are true for the second largest owner, Wellington Management Group Llp, which owns 5,673,374 shares of the stock are valued at $60.59 million. The third largest holder is Oppenheimerfunds, Inc., which currently holds $47.23 million worth of this stock and that ownership represents nearly 9.97% of its market capitalization.GlycoMimetics, Inc. 13F Filings
At the end of September reporting period, 43 institutional holders increased their position in GlycoMimetics, Inc. (NASDAQ:GLYC) by some 3,320,733 shares, 37 decreased positions by 3,202,383 and 16 held positions by 39,979,759. That puts total institutional holdings at 46,502,875 shares, according to SEC filings. The stock grabbed 11 new institutional investments totaling 658,761 shares while 10 institutional investors sold out their entire positions totaling 1,968,219 shares.GlycoMimetics, Inc. (NASDAQ:GLYC) Insider Trades
Multiple company employees have indulged in significant insider trading. GlycoMimetics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that SVP of Research, CSO Magnani John L. has sold 25,000 shares of GlycoMimetics, Inc. (GLYC) in trading session dated Oct. 18, 2018. These shares are worth $350,250 and were traded at $14.01 each. The SEC filing shows that Hahn Brian M. performed a sale of 19,345 shares. The CFO disposed these shares by way of transaction on Jun. 11, 2018. The company’s shares were given away at $18.04 per share worth to an income of some $348,984 on account of Hahn Brian M..
10% Owner, Sandell Scott D, sold 9,539 common shares of GlycoMimetics, Inc. (GLYC) in the open market. In a transaction dated May. 10, 2018, the shares were put up for sale at an average price of $17.81, raking in a sum of $169,890. After this sale, 9,089,041 common shares of GLYC are directly owned by the insider, with total stake valued at $97,070,958.
In the transaction dated May. 10, 2018, the great number of shares disposed came courtesy the 10% Owner; New Enterprise Associates 10 L disposed a total of 9,539 shares at an average price of $17.81, amounting to approximately $169,890. The insider now directly owns 4,995,664 shares worth $53,353,692.GlycoMimetics, Inc. (GLYC) Analyst Guide
Several analysts have released their opinion on GlycoMimetics, Inc. (NASDAQ:GLYC), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 4 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.67 average brokerage recommendation.